FDA Investigator Marsha W Major
Marsha W Major has inspections in 1 countries as of 11 Aug 2023. Marsha W Major has collaborated with a combinined 2482 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
11 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amber D Brodas,
Andrea A Branche,
Andrea George, PhD,
Angel K Sandhu,
Anh M Lac,
Ann Marie Montemurro,
Ann Marie Schofield,
Anna Marie Schofield,
Antonina Aydanian,
Barbara J Wilcox, PhD,
Brentley S Collins,
Bruce D Meade,
Calvin B Koerner,
Carl Lee,
Carole L Jones,
CDR Donald Ertel,
Charles Jewell,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Christopher R Czajka,
Cynthia Jim, CSO,
Cynthia L Kelley,
Daniel J Roberts,
David E Bailey,
David J Hafner,
David J Hapner,
Deborah M Trout,
Debra L Pagano,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Diane L Raccasi,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dustin R Abaonza,
Emily Shacter,
Eric L Dong, BS,
Freyja V Lynn,
Gene D Arcy,
Gerald Feldman,
Gerald M Feldman, PhD,
Helen B Ricalde,
Henry K Lau,
Henry X Lau,
Holly Brevig,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James C Maclaughlin,
James R Evans,
Jean Lhu Primmer,
Jeanne Fringer, PhD,
Jeffrey M Watson,
Jennifer L Bridgewater,
Joan Johnson,
Joan T Briones,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joshua S Hunt,
Julie D Bringger,
Karen L Kosar,
Kevin A Gonzalez,
Kevin P Foley,
Kristina L Conroy,
Lakisha M Williams,
Lance M De Souza, MBA,
Lata C Mathew, PhD,
Laurie P Norwood,
LCDR Jennifer H Rhyu,
Linda Thai,
Linh Tu,
Lisa P Oakes,
Lisa Pierce Oakes,
Lori P Peters,
Mabel M Lee,
Maida Henesian (NMI),
Maria Joselopez Barragan, PhD,
Marie K Kinkade,
Mariza M Jafary,
Marjorie A Shapiro, PhD,
Marsha W Nasur,
Martha T Olone,
Mary Davis Lopez,
Mate Tolnay,
Matthew A Spataro,
Michael Shanks, MS,
Michele L Forster, PhD,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Milan S Blake,
Min Shanma Liu,
Myra K Casey,
Nancy T Waites,
Nayan J Patel,
Nayan Patel,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Patsy J Domingo,
Paul Mouris,
Paula A Trost,
Perry T Nichols,
Peter E Baker,
Peter Kessler, PhD,
Prabhu P Raju,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Richard W Thornton,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert Jennings,
Robert W Jennings,
Rose M Ashley,
Sandra S Saniga,
Sarah B Tanksley,
Scott E Norris,
Scott N Lim,
Serge Beaucage,
Shelley H Beausoleil,
Shelley L Waring,
Sherri J Jackson,
Sidney B Priesmeyer,
Simone E Pitts,
Stephanie A Slater, MS,
Steven C Derrick,
Stuart W Russell,
Susan F Laska, MS,
Susan M Jackson,
Thea C Grome,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Tina S Roecklein,
Truong Xuan Nguyen (Andy),
Wayne E Seifert,
William D Tingley,
William V Millar,
Yi Wang, PhD,
Yvins Dezan
Marsha W Major's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2000 | EIR | Corixa Corporation - EIR, 2000-02-17 |
| August, 2000 | EIR | Genentech, Inc. - EIR, 2000-08-24 |
| February, 2000 | FDA 483 | Corixa Corporation - Form 483, 2000-02-17 |
| February, 2000 | FDA 483 Response | Corixa Corporation - Form 483R, 2000-05-03 |
| June, 2000 | FDA 483 | Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2000-06-13 |
| August, 2000 | FDA 483 | Genentech, Inc. - Form 483, 2000-08-24 |
| August, 2000 | FDA 483 Response | Genentech, Inc. - Form 483R, 2001-01-08 |
| October, 2000 | FDA 483 | Emergent Biodefense Operations Lansing LLC - Form 483, 2000-10-26 |
| October, 2000 | EIR | Emergent Biodefense Operations Lansing LLC - EIR, 2000-10-26 |
| October, 2000 | FDA 483 Response | Emergent Biodefense Operations Lansing LLC - Form 483R, 2000-12-05 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more